TY - JOUR
T1 - Functional differences between protamine preparations for the transfection of mRNA
AU - Jarzebska, Natalia Teresa
AU - Lauchli, Severin
AU - Iselin, Christoph
AU - French, Lars E
AU - Johansen, Pal
AU - Guenova, Emmanuella
AU - Kündig, Thomas M
AU - Pascolo, Steve
PY - 2020/12
Y1 - 2020/12
N2 - Protamine is a natural cationic peptide mixture used as a drug for the neutralization of heparin and in formulations of slow-release insulin. In addition, Protamine can be used for the stabilization and delivery of nucleic acids (antisense, small interfering RNA (siRNA), immunostimulatory nucleic acids, plasmid DNA, or messenger RNA) and is therefore included in several compositions that are in clinical development. Notably, when mixed with RNA, protamine spontaneously generates particles in the size range of 20-1000 nm depending on the formulation conditions (concentration of the reagents, ratio, and presence of salts). These particles are being used for vaccination and immuno-stimulation. Several grades of protamine are available, and we compared them in the context of complex formation with messenger RNA (mRNA). We found that the different available protamine preparations largely vary in their composition and capacity to transfect mRNA. Our data point to the source of protamine as an important parameter for the production of therapeutic protamine-based complexes.
AB - Protamine is a natural cationic peptide mixture used as a drug for the neutralization of heparin and in formulations of slow-release insulin. In addition, Protamine can be used for the stabilization and delivery of nucleic acids (antisense, small interfering RNA (siRNA), immunostimulatory nucleic acids, plasmid DNA, or messenger RNA) and is therefore included in several compositions that are in clinical development. Notably, when mixed with RNA, protamine spontaneously generates particles in the size range of 20-1000 nm depending on the formulation conditions (concentration of the reagents, ratio, and presence of salts). These particles are being used for vaccination and immuno-stimulation. Several grades of protamine are available, and we compared them in the context of complex formation with messenger RNA (mRNA). We found that the different available protamine preparations largely vary in their composition and capacity to transfect mRNA. Our data point to the source of protamine as an important parameter for the production of therapeutic protamine-based complexes.
KW - Cells, Cultured
KW - Drug Compounding/methods
KW - HEK293 Cells
KW - Humans
KW - Leukocytes, Mononuclear/drug effects
KW - Particle Size
KW - Protamines/chemical synthesis
KW - RNA, Messenger/chemical synthesis
KW - Transfection/methods
UR - https://www.scopus.com/pages/publications/85089501888
U2 - 10.1080/10717544.2020.1790692
DO - 10.1080/10717544.2020.1790692
M3 - Article
C2 - 32804028
SN - 1071-7544
VL - 27
SP - 1231
EP - 1235
JO - Drug delivery
JF - Drug delivery
IS - 1
ER -